| ²é¿´: 813 | »Ø¸´: 3 | |||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
idlerenͳæ (СÓÐÃûÆø)
|
[½»Á÷]
ҽѧ·Ö×Ó²¡¶¾Ñ§ÀíÂÛ¿Î
|
||||
|
¹Û¿´µØÖ· http://mvlab-fudan.cn/xxyd/hhh9.htm ¡¡ ÄÚÈݰüÀ¨£º ҽѧ·Ö×Ó²¡¶¾Ñ§ÀíÂۿογ̱í.pdf 1.²¡¶¾Ñ§ÃæÁÙµÄÌôÕ½:ÐÂÏÖºÍÔÙÏÖ²¡¶¾¸ÐȾ(ÎÅÓñ÷Ժʿ) £¨1£©¿Î¼þ/molecular virology 2.²¡¶¾½á¹¹¡¢ºËËáºÍµ°°×£¨Ô¬Õýºê£© £¨1£©¿Î¼þ/virus cultivation, detection and genetics £¨2£©¿Î¼þ/Viral Structure £¨3£©²Î¿¼ÍøÒ³/Microbiology and immunology on-line £¨4£©²Î¿¼ÍøÒ³/Immunology Overview 3.²¡¶¾¸´ÖƼ°Óëϸ°ûÏ໥×÷Óã¨Ô¬Õýºê£© £¨1£©¿Î¼þ/Viral replication and interaction with host cells 4.¿¹²¡¶¾¸ÐȾÃâÒߣ¨öĵӣ© £¨1£©¿Î¼þ/anti-viral 5.²¡¶¾³ÖÐøÐÔ¸ÐȾµÄ»úÖÆ£¨öĵӣ© £¨1£©¿Î¼þ/Viral Persistent Infection 6.¿¹²¡¶¾ÖƼÁ(ÍõÓÂÏè) £¨1£©¿Î¼þ/Antiviral Agents 7.·Ö×Ó²¡¶¾Ñ§Õï¶ÏµÄ¼¼ÊõºÍÔÀí(ºúÜ¿ÎÄ) £¨1£©¿Î¼þ/¸ÎÑײ¡¶¾ºËËáµÄ·Ö×ÓÉúÎïѧ¼ì²â·½·¨ºÍÓ¦Óà 8.²¡¶¾ÒßÃçÑо¿µÄÏÖ×´ÓëδÀ´£¨öĵӣ© £¨1£©¿Î¼þ/vaccine 9.²¡¶¾ÓëÖ×Áö£¨öĵӣ© £¨1£©¿Î¼þ/virus-tumor 10.³¦µÀ²¡¶¾£¨Íõ¼Ò¶°£© £¨1£©¿Î¼þ/Enteroviruses 11.¸ÎÑײ¡¶¾£¨Í¯ÎÄÑࣩ £¨1£©¿Î¼þ/Hepatitis Virus 12.Á÷¸Ð²¡¶¾¡¢SARS²¡¶¾µÈºôÎüµÀ¸ÐȾ²¡¶¾£¨Ðí±ó£© £¨1£©¿Î¼þ/Á÷¸Ð²¡¶¾ÓëSARS 13.ÈËÐ󹲸ÐȾµÄ΢ÉúÎïºÍÉúÎïÕ½µÄ·ÀÓù£¨ÅËÎÀ£© £¨1£©¿Î¼þ/ÉúÎïÎäÆ÷ºÍÉúÎï·ÀÓù 14.²¡ÔÉúÎïµÄ¿¹Ì幤³Ì£¨³Ìѵ¼Ñ£© £¨1£©¿Î¼þ/monoclonal antibody 15.HIV²¡¶¾Ñ§ºÍHIVÒßÃç(¬ºéÖÞ) £¨1£©¿Î¼þ/Aids 16.²¡¶¾·Ö×ÓÁ÷Ðв¡Ñ§Ñо¿(Ðìì®) £¨1£©¿Î¼þ/Introduction to Molecular Epidemiology |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
²Î¿¼Êé¼® | ÎÒµÄÐÂÁìÓò |
» ²ÂÄãϲ»¶
ÇóbÇøÔºÐ£µ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤¿¼Ñе÷¼Á
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
347Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
×Ü·Ö293Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
359Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¸÷λÀÏʦÄúºÃ£º±¾È˳õÊÔ372·Ö
ÒѾÓÐ5È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
idleren
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 99.5
- Ìû×Ó: 55
- ÔÚÏß: 54·ÖÖÓ
- ³æºÅ: 153523
- ×¢²á: 2006-01-02
- רҵ: ÉúÎï
4Â¥2006-08-17 22:30:43
luyunxia0514
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1422
- ºì»¨: 1
- Ìû×Ó: 327
- ÔÚÏß: 16.7Сʱ
- ³æºÅ: 215901
- ×¢²á: 2006-03-11
- רҵ: ÌÇÄò²¡
3Â¥2006-08-17 20:57:40













»Ø¸´´ËÂ¥

